baber/WOPTO huggingface dataset:
Patent NZ-243031-A (NZ)
Title: Heterocyclyl-substituted quinolizine derivatives and pharmaceutical
Inventor: GITTOS MAURICE WARD
IPC: A61P27/06
Filed: 1992-06-05
Abstract: This invention relates to derivatives of formula <CHEM>  wherein  A is =H2, =O, =(H) (OH), NOR1, or <CHEM>  with n being 2 or 3,  X and Y are O or S,  R1 is H or alkyl,  R2 is H, halogeno, alkyl, alkoxy, OH, -CN or C(O)NH2,  Z is O, S or NR1,  Q is a heterocyclic or carbocyclic moiety of the formulae <CHEM>   <CHEM> to the intermediates and processes for their preparation, to their ability to induce a blockage of 5HT3 receptors, and to their end-use application in the treatment of chemotherapeutically-induced nausea and vomiting, as anti-anxiety agents, in the symptomatic treatment of pain associated with migraine, as anti-arrhythmic agents, in the treatment of cognitive disorders, in treating hallucinatory endogenous psychoses of the type manifested in patients suffering from schizophrenia, and mania, in the treatment of glaucoma and for stimulating gastric motility, and to combat drug abuse.
Patent NZ-279377-A (NZ)
Title: Monoclonal antibody specific for tumour rejection antigen precursor mage-1 and mage-1 derivatives
Inventor: CHEN YAO-TSENG
IPC: C12P21/08
Filed: 1995-01-05
Abstract: The invention relates to monoclonal antibodies which specifically bind to the tumor rejection antigen precursor molecule MAGE-1, hybridomas which produce these monoclonal antibodies, and their use. Also described is a recombinant form of MAGE-1, peptides which are useful as immunogens, and immunogenic compositions containing the peptides and an adjuvant.
Patent NZ-284746-A (NZ)
Title: Compost curing system has augers and conveyors arranged in a v formation
Inventor: FINN LARRY JAMES
IPC: C05F17/02
Filed: 1995-04-05
Abstract: A compost curing system utilizing a compost turner of generally V-shaped configuration, one leg of the "V" being formed by counter-rotating ribbon augers and the other leg of the "V" being formed by pair of over-under conveyors, the lower conveyor being adjustably extendable to vary the throw of the conveyor system. The legs of the "V" are piviotally interconnected to permit their angular adjustment and are pivotally mounted on a frame structure for attachment to a motorized conveyance. The system includes means for injecting air into compost undergoing treatment and air collection and air treatment apparatus for controlling the temperature of process air emanating from the compost pile for reuse and for deodorizing the air prior to its release to the atmosphere.
Patent NZ-289114-A (NZ)
Title: Biodegradable mineral-fibre composition
Inventor: BERNARD JEAN LUC
IPC: C03C13/00
Filed: 1995-06-19
Abstract: A biologically degradable mineral-fiber composition characterized by the following constituents in percent by weight: SiO2: 45 to 60, Al2O3: less than 2, CaO 7: to 18, MgO: 4 to 10, Na2O: 7 to 20, K2O: 0 to 4, B2O3: 1 to 12, P2O5: 0 to 4, diverse: 0 to 5, Na2O: + K2O: 7 to 24, CaO + MgO: more than 15.5 and up to 25, BaO: 0 to 5, TiO2: 0 to 4, Cr2O3: 0 to 1.5, Fe2O3: 0 to 3.
Patent NZ-296936-A (NZ)
Title: Process for preparing partially dehydrated nonfrozen compressed vegetables having a moisture content of 15-60%
Inventor: LEWIS VICTOR MARCUS
IPC: A23L19/00
Filed: 1995-12-08
Abstract: The present invention is directed to a process of preparing and/or preserving a partially dehydrated vegetable which is capable of being preserved at or about freezer temperatures, and the product produced thereby.
Patent NZ-319674-A (NZ)
Title: A depilatory composition with improved rinsing properties comprising a depilating agent, thixotropic agent and fatty materials
Inventor: DELAGNEAU HUBERT
IPC: A61K8/26
Filed: 1996-10-14
Abstract: A depilatory composition has improved rinsing properties by the inclusion of from 0.25% to 6% of a thixotropic agent and from 5% to 10.5% of fatty materials. Preferred thixotropic agents are smectite clays, bentonites and synthetic nectorite clays.
Patent NZ-328575-A (NZ)
Inventor: BOWIS MARTYN EVAN
IPC: D21J1/04
Filed: 1998-08-21
Abstract: diaphragm thermoformer for thermoforming a wood fibres-thermoplastic composite material such as wood fibres and polypropylene comprises at least one pair of flexible diaphragms 26 mountable adjacent a mould 29 on one side of the pair of diaphragms and an inlet into and outlet from a space between the diaphragms enabling hot fluid to be circulated between the diaphragms to heat a wood fibres-thermoplastic composite material placed between the diaphragms and the mould.   A space is on the other side of the pair of diaphragms.  A fluid under pressure may be introduced into the space, to force the diaphragms and the wood fibres-thermoplastic composite material against the mould after heating and cause the removal of the hot fluid from between diaphragms 26, to shape the wood fibres-thermoplastic composite material to a mould.
Patent NZ-329645-A (NZ)
Title: Process for producing light olefins from feed having methane and/or ethane using methanol plant combined with oxygenate conversion processing
Inventor: MARKER TERRY L
IPC: C07C41/05
Filed: 1998-01-27
Abstract: Light olefins (72, 74, 76) are produced from a hydrocarbon gas stream (50) by a combination of steam reforming (54), oxygenate production (58), and oxygenate conversion (66) to olefin wherein a crude methanol steam (60) - produced in the production of oxygenates and comprising methanol, light ends, and heavier alcohols - is passed directly to the oxygenate conversion zone (66) for the production of light olefins. Furthermore, the combination provides the synergy for increased catalyst life and reduced water treatment costs by recycling by-product water (71) produced in the oxygenate conversion zone to provide water to the steam reforming zone (54). The advantage of this integration is the elimination of costly methanol separation and purification steps which result in the overall reduction in the costs of producing the light olefins. In addition, a portion of the by-product water can be combined with a propylene stream to provide a high octane blending component for gasoline. The propylene and butylene fractions produced by the above integrated scheme are further converted to high octane ether and other high value products.   <IMAGE>
Patent NZ-332503-A (NZ)
Title: Discharge lamp with sulfur or selenium fill and a reflector to reflect some light emitted by the fill back into the fill
Inventor: MACLENNAN DONALD A
IPC: H01J17/16
Filed: 1997-05-29
Abstract: A discharge lamp e.g. an electrodeless lamp bulb, comprises an envelope 44, fill 42, which emits light when excited, disposed in the envelope, a source of excitation power coupled to the fill and a reflector (e.g. a non-adherent reflecting jacket 44) disposed around the envelope and configured to reflect some of the light emitted by the fill back into the fill while allowing some light to exit (via aperture 48).  The fill is capable of absorbing light at one wavelength and re-emitting the absorbed light at a different wavelength.  The light emitted from the fill has a first spectral power distribution in the absence of reflection of light back into the fill.  The exiting light has a second spectral power distribution with proportionately more light in the visible region as compared to the first spectral power distribution, wherein the light re-emitted by the fill is shifted in wavelength with respect to the absorbed light and the magnitude of the shift is in relation to an effective optical path length.  The fill may comprise at least one substance selected from the group of sulfur and selenium and a fill density may be selected such that the first spectral power distribution comprises a substantial spectral power component in the ultraviolet region and the second spectral power distribution comprises a reduced spectral power component in the ultraviolet region as compared to the first spectral power distribution.  An optical element 49 may be spaced from the envelope and configured to reflect an unwanted component of light which exited the envelope back into the envelope through the opening 48 in the reflector.
Patent NZ-334977-A (NZ)
Title: Extended wear ophthalmic lens
Inventor: NICOLSON PAUL CLEMENT
IPC: C08L83/08
Filed: 1999-03-31
Abstract: An ophthalmic lens comprising an inner and outer surface, where the inner surface is adapted to rest immediately adjacent to the human cornea having the following properties: (a) an oxygen permeability from the inner to the outer surface in an amount sufficient to prevent sufficient corneal swelling during a period of extended wear, being at least about 70 barrers/mm; (b) ophthalmic compatibility during a period of extended, continuous contact with the ocular environment; and (c) ion or water permeability in an amount sufficient to allow lens movement on the eye and to sustain corneal health and wearer comfort, the sodium ion permeability characterised by either (1) an lonoton lon Permeability Coefficient of greater than about 0.2 x 10-6 cm2/sec or (2) an lonoflux Diffusion Coefficient of greater than about 1.5 x 106 mm2/min. A method for using the lens, a method for forming the lens, a method for screening lens suitable for extended wear, a method for forming a molded polymeric article and a polymer composition having good optical clarity and high oxygen permeability comprising: (a) about 5 to about 94 dry weight percent of a macromer having the formula pictured; wherein: R1 and R2 are selected from C1-C6 alkyl, R3, R4, R5, and R6 are selected from C1-C6 alkylene, R7 and R8 are selected from linear or branched alkylene and bivalent cycloalkylene, R9, R10, R11, and R12 are selected from C1-C2 alkylene, R13 and R14 are selected from C1-C6 alkylene, R15 and R16 are selected from linear or branched lower alkenylene, m and p, independently of one another, are about 3 to about 44, and n is about 13 to about 80, wherein said macromer has a number-average molecular weight of 2000 to 10,000; (b) about 5 to about 60 weight percent of an acrylated or methacrylated siloxane monomer; (c) about 1 to about 30 weight percent of an acrylate or methacrylate monomer; and (d) 0 to 5 weight percent cross-linking agent; wherein said weight percentages are based upon the dry weight of the polymer components
Patent NZ-335969-A (NZ)
Title: Method for controlling and removing dust and other particles from a material
Inventor: MCKENZIE MALCOLM TOM
IPC: B08B6/00
Filed: 1997-12-03
Abstract: A method for controlling and removing dust and other fine particles in a material comprising i) electrostatically charging carrier particles in powder form to give the carrier particles a minimum charge to mass ratio of +/- 1x10<-4>C/kg,  ii) delivering the electrostatically charged carrier particles to the material, whereby the dust and other fine particles in the material agglomerate with the charged carrier particles and iii) removing the resultant agglomerates from the material (for example by vacuuming or brushing). An apparatus for delivering electrostatically charged particles to a material, the apparatus comprising a) a container, in which particles to be electrostatically charged are stored and b) means for delivering the particles from the container to the carpet of fabric material, the delivery means comprising: i) a tube or pipe for delivering the carrier particles to the carpet or fine fabric material; ii) means for expelling particles at high velocity from the container to the material; the tube or pipe being made of such a material that, when carrier particles are passed down the delivery tube at high velocity, a minimum charge to mass ratio of +/- 1x10<-4>C/kg is imparted to the particles by the frictional contact of the particles on the inside of the tube or pipe.
Patent NZ-337208-A (NZ)
Title: sustained release pharmaceutical composition containing both slow release and fast release mini-granules coated with dexfenfluramine
Inventor: HUET DE BAROCHEZ BRUNO
IPC: A61K31/137
Filed: 1998-02-26
Abstract: The pharmaceutical composition for programmed release of dexfenfluramine contains: a) rapid-release mini-granules composed of neutral supports on which dexfenfluramine is deposited and b) slow-release mini granules composed of neutral supports covered by dexfenfluramine and talc coated with a polymer that allows controlled release of the active ingredient and with a surface-active agent.
Patent NZ-500848-A (NZ)
Title: Method for purifying GMP from a lactic raw material
Inventor: NEUMANN FRED
IPC: A23C21/00
Filed: 1998-05-22
Abstract: Process for the ion-exchange treatment of a liquid lactic raw material containing GMP with the purpose of recovering a product that can be used as a protein source and providing GMP in a purified form.  The process involves decationisation of the liquid raw material such that the pH has a value of 1 to 4.5, bringing the liquid into contact with a weak anionic resin of hydrophobic matrix, predominantly in alkaline form up to the stabilized pH, separation of the resin and the liquid product which is recovered, and desorption of GMP from the resin.
Patent NZ-503720-A (NZ)
Title: Nucleotide sequences encoding ApoA-I agonists and their use in pharmaceutical compositions to treat dyslipidemic disorders such as cardiovascular disease
Inventor: DASSEUX JEAN-LOUIS
IPC: A61K48/00
Filed: 1998-09-28
Abstract: Described are genetic approaches to the supply of nucleotide sequences encoding modified forms of the native forms of apolipoprotein A-I (ApoA-I): mature ApoA-I, preproApoA-I and proApoA-I.  The nucleotide sequences include native ApoA-I modified to contain ApoA-I agonists, peptides that mimic the activity of ApoA-I; ApoA-I superagonists, peptides that exceed the activity of native ApoA-I; and modified native ApoA-I having one or more amphipathic helices replaced by the nucleotide sequences of one or more ApoA-I agonists.  The genetic approaches are directed to the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and other disorders such as those associated with endotoxemia septic shock.
Patent NZ-515233-A (NZ)
Title: Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
Inventor: ADNOT SERGE
IPC: A61K35/76
Filed: 2000-04-21
Abstract: The use of a vector comprising a nucleic acid encoding an angiogenic factor is described for use in the preparation of a pharmaceutical composition. The composition is intended for the prevention or treatment of pulmonary hypertension, wherein the angiogenic factor is not VEGF-165. A process for the preparation of a medicament, which can be used, for preventing, ameliorating and/or treating pulmonary is also disclosed.
Patent NZ-515348-A (NZ)
Title: Polymorphs of crystalline (2-Benzhydryl-1-azabicyclo [2,2,2]Oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as NK-1 receptor antagonists
Inventor: ALLEN DOUGLAS JOHN MELDRUM
IPC: C07D453/02
Filed: 2000-06-06
Abstract: The crystalline forms of (2-Benzhydryl-1-azo-bicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxy-benzyl)-amine dihydrochloride having formula (I) wherein the said form is selected from: a hygroscopic dihydrochloride anhydrous form; a nonhygroscopic dihydrochloride dihydrate, Form I polymorph exhibiting a defined x-ray powder diffraction pattern; a nonhygroscopic dihydrochloride dihydrate, Form II polymorph exhibiting a defined x-ray powder diffraction pattern.  Also covered is the use of the said crystalline forms in pharmaceutical compositions, and the use of said crystals in the preparation of medicaments for the treatment of emesis.
Patent NZ-516703-A (NZ)
Title: Prodrug of an ICE inhibitor
Inventor: WANNAMAKER MARION
IPC: A61P31/04
Filed: 2001-05-18
Abstract: Disclosed are compounds of formula I and formula I-A. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by an interleukin-1â converting enzyme (ICE) inhibitor.
Patent NZ-519924-A (NZ)
Title: Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
Inventor: BLANCHARD JEAN CHARLES
IPC: A61K45/06
Filed: 2001-02-07
Abstract: The use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide, a pharmaceutically acceptable salt thereof or a solvate thereof for the preparation of medicinal products that are useful for helping to quit tobacco consumption, in the treatment of nicotine dependence and/or in the treatment of the symptoms of withdrawal from nicotine.
Patent NZ-520208-A (NZ)
Title: Pneumoperitoneum apparatus with independent gas and heated water line separated by water permeable membrane
Inventor: INOUE MASAAKI
IPC: F24F6/00
Filed: 2002-07-15
Abstract: Water permeable membrane 8 is located between inner gas line 3 and outer water line 4.
Patent NZ-524718-A (NZ)
Title: Container, container lid and locking ring with upper and lower radially extending flanges to capture lid against neck of container
Inventor: OLSEN NORMAN DONALD
IPC: B65D45/32
Filed: 2001-09-10
Abstract: A container lid (1) and one segment (100), a closing surface (4) having at its peripheral edge a channel (16) to engage a container rim (8) for sealing said rim (8) and a container opening by said channel (16) and said closing surface (4), said one segment (100) being integral with, captured by said lid (1) so as to prevent separation, said one segment (100) including an axial skirt (26) which extends past said channel (16), said skirt (26) including along a portion thereof a flange (28) at an upper location on said skirt (26) and a second flange (30) at a lower location on said skirt (26), so that said first flange (28) engages said lid (1) and said second flange (30) engages directly or indirectly a locking flange (76) on said container (10), so that it prevents said lid (1) from moving with respect to said container (10).
Patent NZ-525055-A (NZ)
Title: Compounds useful in the treatment of inflammatory diseases
Inventor: ANCLIFF RACHAEL ANNE
IPC: C07D417/12
Filed: 2001-09-28
Abstract: Disclosed are compounds of formula (I), for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of inflammatory diseases.
Patent NZ-525074-A (NZ)
Title: Methods for producing high yields of zygotic-like cotyledonary pine embryos utilizing media that include a disaccharide and glucose
Inventor: GUPTA PRAMOD K
IPC: A01H4/00
Filed: 2003-04-01
Abstract: A method of producing cotyledonary pine embryos whereby embryogenic  pine  tissue  is  cultured  on  a  medium  that contains  a  disaccharide and glucose in a concentration  of less than 3% each, to yield cotyledonary pine embryos.
Patent NZ-529692-A (NZ)
Title: Weed control process
Inventor: SUTTON PETER BERNARD
IPC: A01N43/70
Filed: 2002-07-08
Abstract: A process of controlling triazine-tolerant weeds by the application of a combination of mesotrione and a triazine to the locus of said weeds.
Patent NZ-533286-A (NZ)
Title: Controlling the temperature of a roll with a belt and vacuum plenum
Inventor: BUTSCH WILLIAM J
IPC: B31B50/02
Filed: 2003-01-14
Abstract: Disclosed is a method and apparatus for zone controlling the temperature of a rotating roll. The apparatus (12) includes a roll (30) having a surface (32) at a first temperature and a belt (70) disposed adjacent at least a portion of the surface (32) of the roll (30). The belt (70) contacts the roll surface (32) in a contact region (C) and has a second temperature that is different from the first temperature of the roll (30) such that the belt (70) affects a temperature change in at least a portion of the surface (32) of the roll (30) in the contact region (C) as the roll is rotated.
Patent NZ-538509-A (NZ)
Title: Use of murine genomic regions identified to be involved in tumor development for the development of anit-cancer drugs and diagnosis of cancer
Inventor: TOUW IVO PAUL
IPC: C12Q1/68
Filed: 2003-08-14
Abstract: Disclosed are murine genomic regions identified by retroviral insertional tagging of mice as being involved in tumor development. In particular, the genomic regions involved in leukemia development, as well as their human homologues, and the use of these genomic regions for the identification and development of anti-cancer drugs. These drugs include small molecule inhibitors, antibodies, ribozymes, antisense molecules and RNA interference (RNAi) molecules, that are effective in reducing or eliminating the tumorigenic effects of genetic transformations in these genomic regions and/or eliminating the tumorigenic effects of expression products. Also disclosed are; anti-cancer drugs and their use for the treatment of cancer, pharmaceutical compositions their use compositions for the treatment of cancer.
Patent NZ-541793-A (NZ)
Title: Ceramic based nanoparticles for entrapping photosensitive drug/dye for photodynamic therapy
Inventor: PUDAVAR HARIDAS
IPC: A61K41/00
Filed: 2004-01-26
Abstract: The disclosure relates to methods and compositions for photodynamic therapy. The composition comprises ceramic nanoparticles in which a photosensitive drug/dye is entrapped. The ceramic nanoparticles are made by formation of a micellar composition of the dye. The ceramic material is added to the micellar composition and the ceramic nanoparticles are precipitated by alkaline hydrolysis. The precipitated nanoparticles in which the photosensitive dye/drug is entrapped can be isolated by dialysis. The resulting drug doped nanoparticles are spherical, highly monodispersed, and stable in aqueous system. Irradiation with light of suitable wavelength of the photosensitizing drug entrapped inside nanoparticles resulted in generation of singlet oxygen, which was able to diffuse out through the pores of the ceramic matrix. The drug loaded ceramic nanoparticles can be used as drug carriers for photodynamic therapy. Particularly disclosed is a method of preparing ceramic nanoparticles loaded with one or more photosensitive drugs comprising the steps of : (a) preparing micelles entrapping the photosensitive drugs; (b) adding alkoxyorganosilane to the micelles to form complexes of silica and the micelles; (c) subjecting the complexes of silica and micelles to alkaline hydrolysis to precipitate silica nanoparticles in which the photosensitive drug molecules are entrapped ; and (d) isolating the precipitated nanoparticles by dialysis.
Patent NZ-543607-A (NZ)
Title: Read and/or write station for electronic gaming chips
Inventor: GELINOTTE EMMANUEL
IPC: G06K7/08
Filed: 2004-04-16
Abstract: Station for reading and/or writing in a memory (21) of a token, incorporating an electronic circuit is disclosed. The station includes means for storing the token (12), and a communication unit (20) adapted to exchange information with the memory (21) when the token (12) is positioned in the storage means in an orientation allowing the communication via antenna means (30). The station further includes the antenna means (30) including first (46) and second (47) antennas. Each antenna comprises a first (46') and second (47') loops. The first and second loops (46', 47') are disposed adjacently and at least partly superposed on each other so as together to define an enlarged reading and/or writing area in which transmission quality is substantially homogeneous.
Patent NZ-545130-A (NZ)
Title: Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Inventor: BELL ROBERT G
IPC: A61K31/56
Filed: 2004-07-16
Abstract: Disclosed is the use of estrogen and progestin in the manufacture of a medicament for increasing contraceptive effectiveness in a higher weight female in need thereof, wherein the medicament is formulated into dosage forms of (a) 81 to 110 dosage forms comprising estrogen and progestin; and (b) 2 to 10 dosage forms consisting essentially of estrogen; wherein each of the 81 to 110 dosage forms in (a) is administered sequentially and continuously each day for 81 to 110 consecutive days followed consecutively by sequential and continuous administration of each of the 2 to 10 dosage forms in (b) each day for 2 to 10 consecutive days.